Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

Zymeworks (ZYME) Invested Capital (2021 - 2025)

Zymeworks' Invested Capital history spans 3 years, with the latest figure at $424.3 million for Q3 2023.

  • For Q3 2023, Invested Capital rose 136.06% year-over-year to $424.3 million; the TTM value through Sep 2023 reached $424.3 million, up 136.06%, while the annual FY2022 figure was $493.0 million, 97.9% up from the prior year.
  • Invested Capital for Q3 2023 was $424.3 million at Zymeworks, down from $448.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $493.0 million in Q4 2022 and bottomed at $179.8 million in Q3 2022.
  • The 3-year median for Invested Capital is $353.4 million (2022), against an average of $346.7 million.
  • The largest YoY upside for Invested Capital was 136.06% in 2023 against a maximum downside of 67.66% in 2023.
  • A 3-year view of Invested Capital shows it stood at $249.1 million in 2021, then surged by 97.9% to $493.0 million in 2022, then decreased by 13.92% to $424.3 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Invested Capital are $424.3 million (Q3 2023), $448.9 million (Q2 2023), and $473.5 million (Q1 2023).